XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 16,009 $ 10,692
General and administrative 7,245 4,758
Total operating expenses 23,254 15,450
Loss from operations (23,254) (15,450)
Other income:    
Interest income 218 111
Other income 6  
Total other income 224 111
Net loss attributable to common stockholders $ (23,030) $ (15,339)
Net loss per share, basic $ (0.58) $ (0.39)
Net loss per share, diluted $ (0.58) $ (0.39)
Weighted average shares used to compute net loss per share, basic 39,834,619 39,325,793
Weighted average shares used to compute net loss per share, diluted 39,834,619 39,325,793